Publication | Closed Access

Chronic invasive sinus and intracerebral aspergillosis controlled by combination therapy with micafungin and a daily dose of 400 mg itraconazole oral solution

Intracerebral AspergillosisAntifungal AgentAntifungal AgentsClinical MycologyCombination TherapyDermatologyMedicineChronic Invasive Sinus